Cargando…
Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use
BACKGROUND: Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid found in certain coffee (Coffea) species, fruits (Cupuacu [Theobroma grandiflorum]), and tea (Camellia assamica, var. kucha) that has anti-inflammatory, analgesic, and neuro-locomotor properties. Recent preliminary research ha...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711067/ https://www.ncbi.nlm.nih.gov/pubmed/26766930 http://dx.doi.org/10.1186/s12970-016-0113-3 |
_version_ | 1782409912342544384 |
---|---|
author | Taylor, Lem Mumford, Petey Roberts, Mike Hayward, Sara Mullins, Jacy Urbina, Stacie Wilborn, Colin |
author_facet | Taylor, Lem Mumford, Petey Roberts, Mike Hayward, Sara Mullins, Jacy Urbina, Stacie Wilborn, Colin |
author_sort | Taylor, Lem |
collection | PubMed |
description | BACKGROUND: Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid found in certain coffee (Coffea) species, fruits (Cupuacu [Theobroma grandiflorum]), and tea (Camellia assamica, var. kucha) that has anti-inflammatory, analgesic, and neuro-locomotor properties. Recent preliminary research has also reported increased feelings of energy, reduced fatigue, and strong effects on improving focus, concentration, and motivation to exercise. The purpose of this study was to examine the safety and non-habituating effects of TeaCrine®, a nature-identical, chemically equivalent bioactive version of theacrine. METHODS: Sixty healthy men (mean ± SD age, height, weight: 22.9 ± 4.7 years, 183.5 ± 9.2 cm, 86.5 ± 13.7 kg) and women (22.3 ± 4.5 years, 165.2 ± 12.3 cm, 69.0 ± 17.4 kg) were placed into one of three groups: placebo (PLA, n = 20), 200 mg TeaCrine® (LD, n = 19) or 300 mg Teacrine® (HD, n = 21) and ingested their respective supplement once daily for 8 weeks. Primary outcomes were fasting clinical safety markers (heart rate, blood pressure, lipid profiles, hematologic blood counts, biomarkers of liver/kidney/immune function) and energy, focus, concentration, anxiety, motivation to exercise, and POMS measured prior to daily dosing to ascertain potential tachyphylactic responses and habituation effects. Data were analyzed via two-way (group × time) ANOVAs and statistical significance was accepted at p < 0.05. RESULTS: All values for clinical safety markers fell within normal limits and no group × time interactions were noted. No evidence of habituation was noted as baseline values for energy, focus, concentration, anxiety, motivation to exercise, and POMS remained stable in all groups across the 8-week study protocol. CONCLUSIONS: These findings support the clinical safety and non-habituating neuro-energetic effects of TeaCrine® supplementation over 8 weeks of daily use (up to 300 mg/day). Moreover, there was no evidence of a tachyphylactic response that is typical of neuroactive agents such as caffeine and other stimulants. |
format | Online Article Text |
id | pubmed-4711067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47110672016-01-14 Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use Taylor, Lem Mumford, Petey Roberts, Mike Hayward, Sara Mullins, Jacy Urbina, Stacie Wilborn, Colin J Int Soc Sports Nutr Research Article BACKGROUND: Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid found in certain coffee (Coffea) species, fruits (Cupuacu [Theobroma grandiflorum]), and tea (Camellia assamica, var. kucha) that has anti-inflammatory, analgesic, and neuro-locomotor properties. Recent preliminary research has also reported increased feelings of energy, reduced fatigue, and strong effects on improving focus, concentration, and motivation to exercise. The purpose of this study was to examine the safety and non-habituating effects of TeaCrine®, a nature-identical, chemically equivalent bioactive version of theacrine. METHODS: Sixty healthy men (mean ± SD age, height, weight: 22.9 ± 4.7 years, 183.5 ± 9.2 cm, 86.5 ± 13.7 kg) and women (22.3 ± 4.5 years, 165.2 ± 12.3 cm, 69.0 ± 17.4 kg) were placed into one of three groups: placebo (PLA, n = 20), 200 mg TeaCrine® (LD, n = 19) or 300 mg Teacrine® (HD, n = 21) and ingested their respective supplement once daily for 8 weeks. Primary outcomes were fasting clinical safety markers (heart rate, blood pressure, lipid profiles, hematologic blood counts, biomarkers of liver/kidney/immune function) and energy, focus, concentration, anxiety, motivation to exercise, and POMS measured prior to daily dosing to ascertain potential tachyphylactic responses and habituation effects. Data were analyzed via two-way (group × time) ANOVAs and statistical significance was accepted at p < 0.05. RESULTS: All values for clinical safety markers fell within normal limits and no group × time interactions were noted. No evidence of habituation was noted as baseline values for energy, focus, concentration, anxiety, motivation to exercise, and POMS remained stable in all groups across the 8-week study protocol. CONCLUSIONS: These findings support the clinical safety and non-habituating neuro-energetic effects of TeaCrine® supplementation over 8 weeks of daily use (up to 300 mg/day). Moreover, there was no evidence of a tachyphylactic response that is typical of neuroactive agents such as caffeine and other stimulants. BioMed Central 2016-01-13 /pmc/articles/PMC4711067/ /pubmed/26766930 http://dx.doi.org/10.1186/s12970-016-0113-3 Text en © Taylor et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Taylor, Lem Mumford, Petey Roberts, Mike Hayward, Sara Mullins, Jacy Urbina, Stacie Wilborn, Colin Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use |
title | Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use |
title_full | Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use |
title_fullStr | Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use |
title_full_unstemmed | Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use |
title_short | Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use |
title_sort | safety of teacrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711067/ https://www.ncbi.nlm.nih.gov/pubmed/26766930 http://dx.doi.org/10.1186/s12970-016-0113-3 |
work_keys_str_mv | AT taylorlem safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe AT mumfordpetey safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe AT robertsmike safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe AT haywardsara safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe AT mullinsjacy safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe AT urbinastacie safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe AT wilborncolin safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe |